Table 1.
Mean Before Matching |
Mean After Matching |
|||||||
---|---|---|---|---|---|---|---|---|
NCI | Outside | Difference | p Value | NCI | Outside | Difference | p Value | |
No. pts | 620 | 310 | – | – | 510 | 310 | – | – |
Age | 62.1 | 65.4 | 3.2 | <0.0001 | 65.6 | 65.4 | −0.2 | 0.7328 |
PSA (ng/ml) | 11.9 | 10 | −1.9 | 0.5437 | 10.4 | 10 | −0.5 | 0.5521 |
% Suspicion: | <0.0001 | 0.9543 | ||||||
Low | 11 | 6.5 | −4.5 | 6.2 | 6.5 | 0.3 | ||
Moderate | 70.6 | 88.7 | 18.1 | 89.4 | 88.7 | −0.7 | ||
High | 18.4 | 4.8 | −13.5 | 4.4 | 4.8 | 0.4 | ||
% Prior neg biopsy | 68.5 | 60 | −8.5 | 0.0119 | 64.6 | 60 | −4.6 | 0.2343 |
% CDR: | ||||||||
By FB | 40 | 53.2 | 13.2 | 0.0002 | 39.1 | 53.2 | 14.2 | 0.0054 |
By SB + FB | 47.3 | 64.5 | 17.3 | <0.0001 | 47.2 | 64.5 | 17.3 | 0.0004 |
% Upgrading: | ||||||||
By FB | 38.2 | 33 | −5.2 | 0.2754 | 26.1 | 33 | 6.9 | 0.2701 |
By random biopsy | 22.2 | 29.5 | 7.3 | 0.0832 | 32.3 | 29.5 | −2.8 | 0.6829 |
Clinically significant* by FB | 21.2 | 20.5 | −0.7 | 0.9487 | 17.5 | 20.5 | 3 | 0.5987 |
Clinically significant* by SB | 6.8 | 9.5 | 2.7 | 0.3627 | 14.7 | 9.5 | −5.2 | 0.244 |
Defined as Gleason 3 + 4 = 7 or greater.